Hyro Lands on 2026 NY Digital Health 100 as Funding, Deployments and AI Agent Capabilities Scale

New updates have been reported about Hyro.

Hyro has been named to the 2026 New York Digital Health 100 (DH100), underscoring the company’s growing influence as a provider of responsible AI agents for healthcare and its strategic role in the New York digital health ecosystem. The DH100 recognition, tied to Digital Health New York’s annual Healthcare Innovation Report, highlights Hyro specifically for patient engagement as health systems look to automate high-volume workflows and reduce friction in access to care. CEO and co-founder Israel Krush framed the accolade as validation of Hyro’s strategy to use agentic AI to streamline the patient journey across channels, reinforcing the company’s positioning as a core infrastructure player for health systems’ digital front doors.

The recognition comes on the heels of significant operational and financial milestones for Hyro, including a $45 million strategic growth round that lifts total funding to roughly $95 million and supports expansion of its Responsible AI Agent Platform. Backed by Healthier Capital, Norwest and strategic investors such as Bon Secours Mercy Health and ServiceNow Ventures, Hyro is using the new capital to scale capabilities like Proactive Px™, aimed at outbound and proactive patient engagement. The platform is now deployed across more than 50 health systems, including Tampa General Hospital, Sutter Health, Prisma Health and Piedmont Healthcare, collectively engaging over 30 million patients and automating in excess of 85% of routine interactions. For executives, this combination of fresh capital, accelerating adoption, and measurable automation performance signals a company transitioning from proof-of-concept to scaled execution, with implications for reduced operating costs, improved patient throughput and stronger omnichannel engagement as health systems increasingly prioritize trustworthy, compliant AI infrastructure.